Residual γH2AX after irradiation of human lymphocytes and monocytes in vitro and its relation to late effects after prostate brachytherapy

Radiotherapy and Oncology

Volumn 86, Issue 3, 2008, Pages 336-346

  Olive, Peggy L ^a   Banáth, Judit P ^a   Keyes, Mira ^b  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

DNA repair; Normal tissue damage; Predictive assays; Prostate brachytherapy; H2AX

Indexed keywords

HISTONE H2AX; NUCLEAR PROTEIN; PROTEIN GAMMA H2AX; UNCLASSIFIED DRUG; H2AFX PROTEIN, HUMAN; HISTONE;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIOSENSITIVITY; BIOSYNTHESIS; COMPARATIVE STUDY; LYMPHOCYTE; METABOLISM; PROSTATE TUMOR; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TIME; X RAY;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DNA BREAKS, DOUBLE-STRANDED; HISTONES; HUMANS; LYMPHOCYTES; MALE; MONOCYTES; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; X-RAYS;

EID: 40249086612     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.09.002     Document Type: Article

References (51)

1. J.P. Banath S.H. MacPhail P.L. Olive Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines Cancer Res 64 2004 7144 7149
2. C.H. Bassing K.F. Chua J. Sekiguchi Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX Proc Natl Acad Sci USA 99 2002 8173 8178
3. W.A. Brock S.L. Tucker F.B. Geara Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer Int J Radiat Oncol Biol Phys 32 1995 1371 1379
4. J.A. Cesaretti R.G. Stock S. Lehrer ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer Int J Radiat Oncol Biol Phys 61 2005 196 202
5. A.J. Coldman N. Phillips T.A. Pickles Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity CMAJ 168 2003 31 35
6. S. Damaraju D. Murray J. Dufour Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer Clin Cancer Res 12 2006 2545 2554
7. E. Dikomey K. Borgmann J. Peacock H. Jung Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed Int J Radiat Oncol Biol Phys 56 2003 1194 1200
8. V. Gorbunova A. Seluanov Making ends meet in old age: DSB repair and aging Mech Ageing Dev 126 2005 621 628
9. P.D. Grimm J.C. Blasko J.E. Sylvester R.M. Meier W. Cavanagh 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy Int J Radiat Oncol Biol Phys 51 2001 31 40
10. K. Hamasaki K. Imai K. Nakachi N. Takahashi Y. Kodama Y. Kusunoki Short-term culture and gammaH2AX flow cytometry determine differences in individual radiosensitivity in human peripheral T lymphocytes Environ Mol Mutagen 48 2007 38 47
11. J. Johansen S.M. Bentzen J. Overgaard M. Overgaard Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy Radiother Oncol 40 1996 101 109
12. T.A. Kato H. Nagasawa M.M. Weil P.C. Genik J.B. Little J.S. Bedford gamma-H2AX foci after low-dose-rate irradiation reveal atm haploinsufficiency in mice Radiat Res 166 2006 47 54
13. T.A. Kato H. Nagasawa M.M. Weil J.B. Little J.S. Bedford Levels of gamma-H2AX Foci after low-dose-rate irradiation reveal a DNA DSB rejoining defect in cells from human ATM heterozygotes in two at families and in another apparently normal individual Radiat Res 166 2006 443 453
14. M. Keyes S. Miller V. Moravan Acute and late urinary toxicity in 606 prostate brachytherapy patients – the BCCA experience Radiother Oncol 80 2006 S41 S42
15. M. Keyes V. Morvan M. Liu B. Jankovic W.J. Morris Rectal toxicity after prostate brachytherapy Radiother Oncol 76 2005 S5 S6
16. M. Keyes D. Schellenberg V. Moravan Decline in urinary retention incidence in 805 patients after prostate brachytherapy: the effect of learning curve? Int J Radiat Oncol Biol Phys 64 2006 825 834
17. D. Klokov S.M. Macphail J.P. Banath J.P. Byrne P.L. Olive Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays Radiother Oncol 80 2006 223 229
18. M. Kuhne E. Riballo N. Rief K. Rothkamm P.A. Jeggo M. Lobrich A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity Cancer Res 64 2004 500 508
19. A. Kurose T. Tanaka X. Huang Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis Cytometry A 68 2005 1 9
20. M.F. Lavin G. Birrell P. Chen S. Kozlov S. Scott N. Gueven ATM signaling and genomic stability in response to DNA damage Mutat Res 569 2005 123 132
21. M. Lobrich J. Kiefer Assessing the likelihood of severe side effects in radiotherapy Int J Cancer 118 2006 2652 2656
22. A.G. Macdonald M. Keyes A. Kruk G. Duncan V. Moravan W.J. Morris Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important? Int J Radiat Oncol Biol Phys 63 2005 155 163
23. S.H. MacPhail J.P. Banath T.Y. Yu E.H. Chu H. Lambur P.L. Olive Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays Int J Radiat Biol 79 2003 351 358
24. S.H. MacPhail J.P. Banath Y. Yu E. Chu P.L. Olive Cell cycle-dependent expression of phosphorylated histone H2AX: reduced expression in unirradiated but not X-irradiated G(1)-phase cells Radiat Res 159 2003 759 767
25. H. Mahrhofer S. Burger U. Oppitz M. Flentje C.S. Djuzenova Radiation induced DNA damage and damage repair in human tumor and fibroblast cell lines assessed by histone H2AX phosphorylation Int J Radiat Oncol Biol Phys 64 2006 573 580
26. F. Marchetti M.A. Coleman I.M. Jones A.J. Wyrobek Candidate protein biodosimeters of human exposure to ionizing radiation Int J Radiat Biol 82 2006 605 639
27. P.J. Mayer C.S. Lange M.O. Bradley W.W. Nichols Age-dependent decline in rejoining of X-ray-induced DNA double-strand breaks in normal human lymphocytes Mutat Res 219 1989 95 100
28. N. Mei H. Imada S. Nomoto N. Kunugita T. Norimura Individual variation and age dependency in the radiosensitivity of peripheral blood T-lymphocytes from normal donors J Radiat Res (Tokyo) 37 1996 235 245
29. R. Mirzayans D. Severin D. Murray Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity Int J Radiat Oncol Biol Phys 66 2006 1498 1505
30. A.J. Morrison X. Shen DNA repair in the context of chromatin Cell Cycle 4 2005 568 571
31. S. Nag R.J. Ellis G.S. Merrick R. Bahnson K. Wallner R. Stock American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy Int J Radiat Oncol Biol Phys 54 2002 462 470
32. N. Nakamura R. Sposto J. Kushiro M. Akiyama Is interindividual variation of cellular radiosensitivity real or artifactual? Radiat Res 125 1991 326 330
33. T. Pickles Current status of PSA screening. Early detection of prostate cancer Can Fam Physician 50 2004 57 63
34. L. Potters C. Morgenstern E. Calugaru 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer J Urol 173 2005 1562 1566
35. M.J. Ramsey D.H. Moore J.F. Briner The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting Mutat Res 338 1995 95 106
36. E.P. Rogakou C. Boon C. Redon W.M. Bonner Megabase chromatin domains involved in DNA double-strand breaks In vivo J Cell Biol 146 1999 905 916
37. E.P. Rogakou W. Nieves-Neira C. Boon Y. Pommier W.M. Bonner Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139 J Biol Chem 275 2000 9390 9395
38. E.P. Rogakou D.R. Pilch A.H. Orr V.S. Ivanova W.M. Bonner DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139 J Biol Chem 273 1998 5858 5868
39. V. Rudat A. Dietz J. Nollert Acute and late toxicity, tumour control and intrinsic radiosensitivity of primary fibroblasts in vitro of patients with advanced head and neck cancer after concomitant boost radiochemotherapy Radiother Oncol 53 1999 233 245
40. N.S. Russell A.C. Begg Editorial radiotherapy and oncology 2002: predictive assays for normal tissue damage Radiother Oncol 64 2002 125 129
41. K.M. Snyder R.G. Stock S.M. Hong Y.C. Lo N.N. Stone Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose–volume histogram analysis Int J Radiat Oncol Biol Phys 50 2001 335 341
42. 125I prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms Brachytherapy 1 2002 83 89
43. N.N. Stone R.G. Stock Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy Brachytherapy 2 2003 32 39
44. N.N. Stone R.G. Stock Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years Urology 69 2007 338 342
45. J.P. Svensson L.J. Stalpers R.E. Esveldt-van Lange Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity PLoS Med 3 2006 e422
46. M. Swift P.J. Reitnauer D. Morrell C.L. Chase Breast and other cancers in families with ataxia-telangiectasia N Engl J Med 316 1987 1289 1294
47. N. Taneja M. Davis J.S. Choy Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy J Biol Chem 279 2004 2273 2280
48. M.P. Van Gellekom M.A. Moerland V.M. Van H.K. Wijrdeman J.J. Battermann Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry Int J Radiat Oncol Biol Phys 63 2005 772 780
49. F.M. Waterman A.P. Dicker Probability of late rectal morbidity in 125I prostate brachytherapy Int J Radiat Oncol Biol Phys 55 2003 342 353
50. C.M. West S.E. Davidson S.A. Elyan Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix Int J Radiat Oncol Biol Phys 51 2001 10 15
51. S.M. Wykes E. Piasentin M.C. Joiner G.D. Wilson B. Marples Low-dose hyper-radiosensitivity is not caused by a failure to recognize DNA double-strand breaks Radiat Res 165 2006 516 524